We recently participated in the Analyst/Investor Meet held by Colgate-Palmolive (India) Ltd. (CLG...
Colgate India hosted its ‘Brands Day’, where it showcased its capability in Oral Care...
Our SELL rating on Colgate was a factor of weak topline delivery and restricted diversification i...
Double digit sales growth YoY: Colgate Palmolive India reported double digit sales growth of 10.6...
The Economic Times Brand World Summit is back with its highly anticipated fifth edition, bringing...
Colgate-Palmolive (India) is currently trading at Rs. 1692.65, up by 66.35 points or 4.08% from i...
Volume trajectory continues to remain subdued * CLGT’s gross margin returned to normativ...
Buy Colgate-Palmolive Ltd CMP: Rs 1657 | Target: Rs 1848 (12%)| SL: Rs 1541 Col...
COLPAL * The FMCG pack is showing resilience while others are seeing profit taking. * Withi...
No surprises. Another year, another weak quarter, as usual 2QFY23 revenues growth of 2.6% YoY ...
Another soft quarter 1QFY23 revenue growth of 2.6% YoY was again underwhelming but not unexpec...
Sustainable growth entails more levers (Personal care) About the stock: Colgate-Palmolive (Ind...
Soft quarter with higher inflation impacted margins; reiterate ADD Our view Company deliver...
Key News Ikea India increases prices of some products as inflation bites IKEA India has inc...
Religare Super Idea** To Read Complete Report & Disclaimer Click Here ...
Derivative Ideas COLPAL shed 1.69% and closed at 1562.8 on 3rd Jun. The stock has been facing ...
Surprise potential and low expectations (also valuation) make the odds in favour; ADD We recog...
Margin headwinds and soft near‐term growth outlook makes us downgrade to ADD despite seemingly un...
In-line performance Colgate Palmolive’s (Colgate) Q3FY22 revenue (up 3.9% YoY) was in li...
Muted show * Colgate delivered a muted performance in Q3FY22, with sales growing by 4% to Rs12...
Brokerage firm Centrum Broking has given a 'buy' call to potential investors for shares o...
The company reported standalone net profit of Rs 252.33 crore for the quarter ended December 31, ...
CONTINUED INNOVATION WILL ENSURE THE COMPANY TO SUSTAIN ITS LEADERSHIP POSITION. The company f...
Margins under pressure; high ad spends for growth About the stock: Colgate-Palmolive (India) (...
Margins under pressure; high ad spends for growth… About the stock: Colgate-Palmolive (...
Sales growth remains tepid; outlook weak * CLGT’s 2QFY22 result was in line with ou...
Religare Super Idea To Read Complete Report & Disclaimer Click Here ...
High promotions and weak margins impact earnings * Colgate reported a 9% miss on earnings in Q...
Below is quote on Colgate-Palmolive -2QFY22 - Result Update by Mr. Amarjeet M...
Underwhelming; that’s an understatement Colgate continues to underwhelm. It is yet to de...
Favourable RM costs; elevated margins to sustain… About the stock: Colgate-Palmolive (I...
Continued weak sales growth; weak outlook ahead * Colgate-Palmolive (CLGT)’s weak sales ...
Slight miss on growth * CLGT reported a slight miss on the topline in Q1. Sales grew 12% (4% m...
Continued weak sales growth, unsustainable margins Downgrade to Neutral * Colgate-Palmolive...
More of the same Domestic revenue growth of 20% (2-year CAGR of 5%) was inline. Volume growth ...
Solid Q4; Outlook optimistic Colgate-Palmolive (India) Ltd. manufactures consumer products in ...
Steady growth; margin beat on lower ad spends * Colgate reported a steady performance in Q4, w...
Key News Colgate-Palmolive India Q4 net profit jumps 54% to Rs 314.6 crore Consumer goods m...
Below are Views On Colgate-Palmolive -4QFY21 by Mr. Amarjeet Maurya - AVP - Mid Ca...
Growth momentum improving * Colgate’s domestic sales growth was better at 10%, driven b...
Healthy recovery, innovation to drive growth Colgate reported a healthy 3QFY21 with 8% YoY net...
Gross margin expansion leads to beat on estimates * Colgate’s (CLGT) EBITDA and PAT gro...